A Double-Blind Confirmatory Study Comparing Rapid-Acting Intramuscular Olanzapine and Rapid-Acting Intramuscular Placebo in Patients With an Exacerbation of Schizophrenia With Acute Psychotic Agitation.

Trial Profile

A Double-Blind Confirmatory Study Comparing Rapid-Acting Intramuscular Olanzapine and Rapid-Acting Intramuscular Placebo in Patients With an Exacerbation of Schizophrenia With Acute Psychotic Agitation.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Jun 2013

At a glance

  • Drugs Olanzapine (Primary)
  • Indications Agitation; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jun 2013 Results presented at the 11th World Congress of Biological Psychiatry.
    • 21 Feb 2012 Actual patient number changed from 90 to 91 as reported by ClinicalTrials.gov.
    • 09 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top